Intrinsiqq
Disc Medicine Inc. logo

Disc Medicine Inc. Insider Trading

IRON

Compare
Last 12 months

Insiders sold $48.8M and bought nothing on the open market.

58% of the selling was scheduled in advance under 10b5-1 plans. Director Kevin Bitterman sold $16.9M on Dec 16, 2025, 34% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2024.

Net open-market
−$48.8M
0 buys · 33 sales
Under a 10b5-1 plan
58%
of the value sold
Insiders who bought / sold
0 / 7
executives and directors
Last open-market buy
Jun 2024
Jun 17, 2024

Get an email when IRON's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 1010b5-1 plan
    William Jacob Savage
    Chief Medical Officer · sold 16,035 at $85.09
    $1.36M
    20% of stake
  • Oct 19 – 2110b5-1 plan
    Kevin Bitterman
    Director · sold 41,825 at avg $80.13
    $3.35M
    76% of stake
  • Sep 11No plan
    Kevin Bitterman
    Director · sold 27,136 at $70.11
    $1.9M
    8.0% of stake
  • Sep 410b5-1 plan
    Kevin Bitterman
    Director · sold 1,689 at avg $79.96
    135K
    11% of stake
  • Sep 1 – 310b5-1 plan
    Kevin Bitterman
    Director · sold 54,496 at avg $80.15
    $4.37M
    80% of stake
  • Aug 24 – 2510b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 9,096 at avg $83.10
    756K
    14% of stake
  • Aug 1710b5-1 plan
    John D Quisel
    Chief Executive Officer · sold 33,000 at avg $79.15
    $2.61M
    13% of stake
  • Aug 1210b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 804 at $82.64
    66K
    1.5% of stake
  • Aug 610b5-1 plan
    Rahul Khara
    Chief Legal Officer · sold 5,000 at $80.00
    400K
    8.7% of stake
  • Jul 1310b5-1 plan
    John D Quisel
    Chief Executive Officer · sold 33,000 at avg $74.96
    $2.47M
    13% of stake
  • Jul 710b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 100 at $82.50
    8K
    0.2% of stake
  • Jun 26 – 2910b5-1 plan
    Rahul Khara
    Chief Legal Officer · sold 2,500 at avg $75.00
    188K
    4.6% of stake
  • Jun 2610b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 300 at $72.50
    22K
    0.5% of stake
  • Jun 2210b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 9,700 at $72.66
    705K
    15% of stake
  • Jun 1810b5-1 plan
    Rahul Khara
    Chief Legal Officer · sold 7,500 at avg $70.22
    527K
    13% of stake
  • Jun 1810b5-1 plan
    John D Quisel
    Chief Executive Officer · sold 34,000 at avg $70.22
    $2.39M
    13% of stake
  • Jun 1610b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 18,612 at avg $69.19
    $1.29M
    26% of stake
  • Apr 13 – 1410b5-1 plan
    Jean M. Franchi
    Chief Financial Officer · sold 6,657 at avg $69.23
    461K
    9.4% of stake
  • Apr 1310b5-1 plan
    William Jacob Savage
    Chief Medical Officer · sold 5,731 at avg $66.38
    380K
    6.7% of stake
  • Mar 210b5-1 plan
    William Jacob Savage
    Chief Medical Officer · sold 7,378 at avg $65.88
    486K
    8.0% of stake
  • Feb 2510b5-1 plan
    Jean M. Franchi
    Chief Financial Officer · sold 353 at $69.06
    24K
    0.5% of stake
  • Feb 17 – 1810b5-1 plan
    Jean M. Franchi
    Chief Financial Officer · sold 11,156 at avg $64.52
    720K
    14% of stake
  • Feb 17No plan
    Rahul Khara
    Chief Legal Officer · sold 2,853 at $62.86
    179K
    5.2% of stake
  • Feb 17No plan
    Pamela Stephenson
    Chief Commercial Officer · sold 5,531 at $62.86
    348K
    6.4% of stake
  • Feb 17No plan
    William Jacob Savage
    Chief Medical Officer · sold 3,256 at $62.86
    205K
    3.4% of stake
  • Feb 17No plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 3,231 at $62.86
    203K
    5.6% of stake
  • Feb 17No plan
    John D Quisel
    Chief Executive Officer · sold 13,264 at $62.86
    834K
    5.5% of stake
  • Jan 2010b5-1 plan
    Rahul Khara
    Chief Legal Officer · sold 1,000 at $69.74
    70K
    2.6% of stake
  • Jan 210b5-1 plan
    Rahul Khara
    Chief Legal Officer · sold 6,500 at avg $78.68
    511K
    15% of stake
  • Dec 17, 2025No plan
    Kevin Bitterman
    Director · sold 754 at avg $91.47
    69K
    5.1% of stake
  • Dec 12, 2025 – Dec 16, 2025No plan
    Kevin Bitterman
    Director · sold 184,123 at avg $91.56
    $16.9M
    34% of stake
  • Dec 15, 202510b5-1 plan
    William Jacob Savage
    Chief Medical Officer · sold 13,093 at avg $91.22
    $1.19M
    15% of stake
  • Dec 11, 202510b5-1 plan
    John D Quisel
    Chief Executive Officer · sold 40,000 at avg $93.05
    $3.72M
    19% of stake
  • Nov 11, 202510b5-1 plan
    Jonathan Yen-Wen Yu
    Chief Operating Officer · sold 30,000 at avg $84.70
    $2.54M
    43% of stake
  • Oct 22, 2025No plan
    AI DMI LLC
    Large holder · sold 744,047 at $80.47
    $59.9M
    21% of stake
  • Oct 15, 2025 – Oct 17, 2025No plan
    Kevin Bitterman
    Director · sold 93,585 at avg $85.97
    $8.05M
    20% of stake
  • Oct 7, 2025 – Oct 8, 2025No plan
    Kevin Bitterman
    Director · sold 90,000 at avg $70.14
    $6.31M
    15% of stake
  • Aug 22, 202510b5-1 plan
    Kevin Bitterman
    Director · sold 2,287 at $61.03
    140K
    0.4% of stake
  • Aug 13, 2025 – Aug 14, 202510b5-1 plan
    Kevin Bitterman
    Director · sold 32,174 at avg $61.11
    $1.97M
    5.1% of stake
  • Aug 5, 202510b5-1 plan
    Kevin Bitterman
    Director · sold 395 at $60.95
    24K
    <0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IRON, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with IRON

CompareIntrinsic value
ACADAcadia Pharmaceuticals Inc.
$17.38-1.19%71
PTGXProtagonist Therapeutics Inc.
$121.40-2.11%62
ELANElanco Animal Health Incorporated
$25.74-2.09%46
COGTCogent Biosciences, Inc.
$26.72-3.70%20
VTRSViatris Inc.
$19.63-1.26%24
ZLABZai Lab Ltd
$21.03-4.06%40
ONCBeOne Medicines Ltd.
$390.94-2.19%67
ANIPAni Pharmaceuticals Inc.
$68.55-0.84%85

Held by ETFs

IRON is in 42 US ETFs. The largest of them, with IRON's weight in each:

Spot a number that looks wrong? Check it in IRON's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IRON

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.